Predicting Favorable Outcomes in Hospitalized Covid-19 Patients

CompletedOBSERVATIONAL
Enrollment

1,415

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions
COVIDCorona Virus InfectionAdverse Event
Interventions
OTHER

EPIC risk score display

Display of risk score/ colored flag in Epic patient list column

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04570488 - Predicting Favorable Outcomes in Hospitalized Covid-19 Patients | Biotech Hunter | Biotech Hunter